Sang-Min Lim

Title: Sang-Min Lim: Innovator in Mitochondrial Therapeutics

Introduction

Sang-Min Lim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions involving mitochondria. His innovative work aims to address various diseases related to mitochondrial dysfunction.

Latest Patents

Sang-Min Lim holds a patent for an "Injection composition containing isolated mitochondria, and use thereof." This patent describes a liquid composition for injection that includes glycine, saccharide, buffer, and isolated mitochondria. The composition is designed to enhance the stability of mitochondria, ensuring their safety and activity when administered to patients. This innovation is particularly relevant for preventing and treating diseases associated with mitochondrial dysfunction and for inhibiting blood clot formation.

Career Highlights

Sang-Min Lim is currently associated with Paean Biotechnology Inc., where he continues to advance his research in mitochondrial therapies. His work is pivotal in developing safe and effective methods for injecting mitochondria into the body, which can significantly improve treatment outcomes for patients suffering from mitochondrial-related diseases.

Collaborations

Sang-Min Lim collaborates with notable colleagues, including Young-Cheol Kang and Kyuboem Han. Their combined expertise contributes to the innovative research and development efforts at Paean Biotechnology Inc.

Conclusion

Sang-Min Lim's contributions to mitochondrial therapeutics represent a significant advancement in biotechnology. His innovative patent and ongoing research efforts hold promise for improving treatment options for patients with mitochondrial dysfunction.